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1. INTRODUCTION
The high-dose-rate (HDR) brachytherapy technique
recently replaced low-dose-rate (LDR) brachytherapy
procedures for various reasons, including the fact that the
treatment time is shorter and patient hospitalization is no
longer necessary. The International Commission on Radia-
tion Units and measurements (ICRU) Report 38 classifies
HDR brachytherapy techniques as those that deliver very
high dose rates (20cGy/min or more)1). This means that any
mistakes made during HDR treatment could have significant
consequences. Thus, the safety of HDR brachytherapy
treatment units should be stringently ensured.
In Korea, a statistical study by the Korean Society for
Therapeutic Radiology and Oncology showed that, in
2006, 1,561 of 37,215 (4.2%) radiation oncology patients
received brachytherapy primarily in order to treat intracav-
itary tumors.2) Thus, far fewer radiation oncology patients
undergo brachytherapy treatments compared to those
who undergo external beam radiation therapy (EBRT).
Nevertheless, shielding for brachytherapy units remains a
crucial consideration when installing or remodeling brachy-
therapy facilities. The National Council on Radiation
Protection and Measurements (NCRP) reports provide
guidelines with regard to shielding design and documen-
tation of radiation safety reports for radiation therapy units.
NCRP Report 49, which was published in 1988, provided
suitable broad-beam tenth value layer shielding data as well
as suitable exposure rate constants for several radioisotopes,
including Iridium-192 which is the most common radio-
isotope used in current HDR brachytherapy practice.3)
NCRP Report 151 suggests a suitable weekly treatment
time for brachytherapy equipment.4) In Korea, the Korea
Institute of Nuclear Safety is the regulatory agency that
regulates nuclear safety matters, including radiation oncol-
ogy facility planning or remodeling. This agency has
established a guideline that radiation oncology departments
can refer to when completing radiation safety reports.
Thirty-eight radiation safety reports for brachytherapy equipment were evaluated to determine the current status of
brachytherapy units in Korea and to assess how radiation oncology departments in Korea complete radiation safety reports.
The following data was collected: radiation safety report publication year, brachytherapy unit manufacturer, type and activity
of the source that was used, affiliation of the drafter, exposure rate constant, the treatment time used to calculate workload and
the HVL values used to calculate shielding design goal values. A significant number of the reports (47.4%) included the
personal information of the drafter. The treatment time estimates varied widely from 12 to 2,400 min/week. There was
acceptable variation in the exposure rate constant values (ranging between 0.469 and 0.592 (R·m2/Ci·hr), as well as in the
HVLs of concrete, steel and lead for Iridium-192 sources that were used to calculate shielding design goal values. There is a
need for standard guidelines for completing radiation safety reports that realistically reflect the current clinical situation of
radiation oncology departments in Korea. The present study may be useful for formulating these guidelines.
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However, it is a general guideline for all radiation treatment
equipments that focuses mainly on linear accelerator-based
radiation therapy. Due to the different characteristics of
radiation treatment equipments, individual guidelines for
each type of treatment equipment may be needed for
completing the radiation safety reports. 
The present study evaluated 38 radiation safety reports
for brachytherapy equipment to determine the current
status of the brachytherapy units in Korea and the quality
of the radiation safety reports that were completed by the
radiation oncology departments. The results support the
notion that standard guidelines specific for brachytherapy
treatment are needed in order to complete radiation safety
reports that reflect the current clinical situation of radiation
oncology departments in Korea. 
2. MATERIALS AND METHODS
Of the 39 brachytherapy units that are currently operat-
ing in Korea, radiation safety reports were available for
38. The following data was collected from these radiation
safety reports: radiation safety report publication year,
brachytherapy unit manufacturer/supplier, type of sources
used, activity of the source, availability and affiliation of
the person who completed the report, exposure rate constant,
the treatment time that was used to calculate workload,
and the half-value-layer (HVL) values that were used to
calculate the shielding design goal values. The number of
radiation safety reports that were published each year was
evaluated to determine the frequency of new brachytherapy
equipment installation or remodeling. Brachytherapy unit
manufacturer data and the radioisotope sources and their
activity were sorted and percentages were obtained to
determine trends in the use of brachytherapy techniques
in terms of dose rates. Whether the persons who completed
the report indicated their affiliations and whether they were
affiliated with the institution or outsourcing companies
were also determined. To determine how well radiation
oncology departments in Korea completed the radiation
safety reports, the exposure rate constants and treatment
times per week that were used for calculating workload
and shielding design goal values were assessed along with
the HVL values that were used to evaluate shielding safety.
Descriptive statistics were used to evaluate the current
status of brachytherapy equipment in Korea and identify
trends in radiation safety report completion. 
3. RESULTS
As shown in Figure 1, radiation safety reports were
published at a fairly constant rate over the period of 1985
and 2010, which was when current brachytherapy units
in Korea were installed. There was an exceptional burst
of reporting in 2001. Table 1 shows that six different
manufacturers supplied brachytherapy units to radiation
oncology departments in Korea, namely, Nucletron, Varian,
MDS Nordion, Buchler, Bebig and Shimadzu. As shown
in Figure 2, Nucletron supplied most of the brachytherapy
units (63.2%), followed by Varian (13.2%), MDS Nordion
(10.5%), Bebig (5.3%), Buchler (5.3%) and Shimadzu
(2.6%). It should be noted that, in 2002, Varian Medical
Systems, Inc. acquired the HDR brachytherapy business
of MDS Nordion, and two of the five equipments supplied
by Varian after 2002 were actually the GammaMed model
of MDS Nordion. 
In total, 33 institutions utilized HDR brachytherapy
techniques with units from Nucletron (N=24), Varian
(N=5) and MDS Nordion (N=44) that used Iridium-192
sources (Table 1). Four institutions employed units that
used three interchangeable sources (Cobalt-60, Cesium-137
and Iridium-192). These units were supplied by Buchler-
3K (N=2) and Bebig-MultiSource (N=2). One institution
used a HDR brachytherapy unit from Shimadzu-Ralstron,
which employed a Cobalt-60 source. 
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Fig. 1. Histogram Showing the Number of Radiation Safety
Reports that are Published Each Year (N=38).
Fig. 2. Manufacturers that Supplied the Currently used
Brachytherapy Units to Radiation Oncology Departments, as
Indicated by a Pie Graph.
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The Nuclear Safety and Security Commission as well
as international guidance setting bodies such as the NCRP
state that the radiation safety report must include the personal
information and qualifications (education, training, and
experience) of the person who performed the survey and
completed the report.4, 5) In the present study, 47.4% of the
radiation safety reports complied with these regulations
by including the personal information of the drafter. Of
the 38 reports, 11 (28.9%) were processed by an applicant
who was affiliated with the institution itself, seven (18.4%)
were processed by an outsourcing company, and the remain-
ing 20 reports (52.6%) failed to include the personal
information of the drafter. 
Since October 4, 2000, radiation safety control could
be performed by an outsourcing company and thus caused
the radiation safety documents that were completed by
outsourcing agencies to increase in number. Indeed, the
present study found that the radiation safety documents
that were completed by outsourcing agencies rose from
6.7% in 1990-1999 to 33.3% in 2000-2009 (Fig.3). At
present (2011), there are 13 outsourcing agencies that can
complete radiation safety reports in Korea.6) However,
despite the introduction of outsourcing agencies, the majority
of the reports containing personal information of the drafter
were still completed by institution-affiliated drafters:
Figure 3 shows that in 1980-1989, 20.0% and 0.0% of the
reports were completed by institution-affiliated personnel
and outsourcing agencies, respectively. Similarly, in 1990-
1999, these values were 13.3% and 6.7%, respectively,
and in 2000-2009, these values were 44.4% and 33.3%,
respectively. 
The Korean Nuclear Safety and Security Commission
and American regulatory agencies such as the Nuclear
Regulatory Commission (NRC) or NCRP require applicants
to include radiation safety shielding calculations in their
radiation safety reports.4) Report 151 of the NCRP defines
workload as ‘the average absorbed dose of radiation
produced by a source over a specified time (most often
one week) at a specific location’.4) Workload is a function
of source activity and treatment time and is expressed by
the following equation:
Γ (exposure rate constant) is exposure rate to activity
at 1m;
f relates cGy to R; 
A is the activity of the source;
t  [treatment time (minutes) per week] is the time when
the radioisotope is actually exposed in the air for
treatment expressed in minutes per week. 
Different Γ, f, A, and t values from the various sources
were used to calculate workload in the radiation safety
reports. As shown in Figure 4, the exposure rate constant
for Iridium-192 sources used to calculate workload ranged
from 0.469 to 0.592 R·m2/Ci·hr, with 0.480 R·m2/Ci·hr being
the most frequently used exposure rate constant (44.7%).
Eight radiation safety reports (21.1%) failed to define the
exposure rate constant. The exposure rate constant for
Fig. 3. Histogram of the Affiliations of the Radiation Safety
Report Drafters, Classified in Intervals of Ten Years.
Table 1. Number of Brachytherapy Units from Various Manufacturing Companies, Types of Sources when Brachytherapy
Equipment Installation/Remodeling was Planned and Types of Sources that are Currently Being used in Korea
Manufacturer/Model
Nucletron-MicroSelectron HDR
Varian- VariSource
MDS Nordion- GM-12i
Buchler- 3k 2 Iridium-192
Number of Equipment
24
5
4
Source(s) planned
Iridium-192
Iridium-192
Iridium-192
Iridium-192,
Cesium-137,
Cobalt-60
Bebig- Multisource 1 Iridium-192
Iridium-192,
Cesium-137,
Cobalt-60
Bebig- Multisource 1 Cobalt-60
Iridium-192,
Cesium-137,
Cobalt-60
Shimadzu- Ralstron 1 Cobalt-60Cobalt-60
Source(s) used
Iridium-192
Iridium-192
Iridium-192
(1)
Cobalt-60 used in the radiation safety reports was either
1.2 or 1.32 R·m2/Ci·hr. Two of the five relevant radiation
safety reports (40.0%) did not cite the exposure rate constant
for the Cobalt-60 source.
Iridium-192 sources with an activity of 10Ci are used
for HDR brachytherapy units. However, five of the radiation
safety reports (13.2%) used Iridium activities of 11Ci, 12Ci
or 13.6Ci to calculate the workload. This was the activity
of the source at the time the equipment was installed or the
shielding design goal was calculated. However, the actual
treatment was carried out with an Iridium activity of 10Ci.
Moreover, a radiation safety report from the radiation
oncology department that performed the Bebig-MultiSource
HDR treatment, which is capable of using three sources
(Cobalt-60, Cesium-137 and Iridium-192), used Cobalt-60
with activity of 2Ci to calculate the workload. Currently,
one department is using a Cobalt-60 source only, while
another department is using an Iridium-192 source. In
addition, a radiation safety report from the radiation oncol-
ogy department that uses a Buchler-3k unit used sources of
five different activities for workload calculation, including
a Cobalt-60 with activity of 1.32Ci, Cesium-137 with
activity of 2.04Ci and 2.08Ci, and Iridium-192 with activity
of 8.35Ci and 6.74Ci. Through a personal interview, this
department explained that at the time of brachytherapy
equipment installation, five sources were used to treat
gynecological cancer patients where a Cobalt-60 source
was inserted into tandem and either two Cesium-137 or
two Iridium-192 sources were inserted into ovoids to treat
the site simultaneously. Currently, only Iridium-192 source
with activity of 10Ci, which is supplied by a local company,
is used for HDR treatment. 
As shown in Figure 5, treatment time per week was
not specifically defined in a large proportion of radiation
safety reports (28.9%). These radiation safety reports
assumed the treatment time to be 40 hr/week (2,400 min/
week), which is used to calculate the workload for linear
accelerators. However, a study by Glasgow and Dillman
has shown that the average treatment time estimate for 10Ci-
Iridium-192 sources is 2 hr/wk (120 min/wk).7) Similarly,
NCRP report 151 estimates the treatment time for such
sources to be 6.7 hr/wk (402 min/wk).4) Thus, a treatment
time assumption of 40 hr/week may be an overestimate.
Of the radiation safety reports that actually calculated the
treatment time, the most frequently used treatment time
estimates used for calculating the workload were 100-
300 min/week (15.8%) and 600-700 min/week (15.8%). 
Various recommended shielding design goal values
were used in the radiation safety reports. The most fre-
quently used shielding design goal value for a controlled
area was 1 mSv/week (21.1%), followed by 0.3 mSv/week,
which is equivalent to 50 mSv/year (10.5%). The most
frequently used shielding design goal value for an uncon-
trolled area was 0.1 mSv/week (23.7%), followed by
0.02 mSv/week (15.8%). Four reports (10.5%) used an
instantaneous dose rate (IDR) of 2.5 mR/hr for controlled
areas and 0.25 mR/hr for uncontrolled areas. 
As shown in Figure 6, the HVL of concrete for Iridium-
192 ranged between 3 and 4.75 cm. The most frequently
used HVL values for Iridium-192 were 4.1cm(23.7%)
and 4.3 cm (28.9%) suggested by NCRP Report 49.3) The
HVL of 3 cm was obtained by the equation:
where µconc = 0.23/cm. 
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Fig. 4. Histogram of the Exposure Rate Constants that were used to Calculate Workload for Iridium-192 Sources.
Fig. 5. Histogram of the Treatment Time Per Week Estimates
that were used to Calculate Workload.
(2)
The HVL values of 4.0 cm, 4.5 cm and 4.55 cm were
obtained by calculations using transmission factor (B value)
and the equation:
Substituting µ from equation (2) into equation (3) yields:
Nine radiation safety reports (23.7%) did not include
concrete HVL values for Iridium-192. 
The HVLs of steel used in the shielding calculation
were 0.9 and 1.3 cm. Most radiation safety reports (65.8%)
either did not use steel for facility shielding or did not
include this HVL for the shielding calculation. 
The HVLs of lead used in the shielding calculations
ranged between 0.2 cm and 0.6 cm. The HVL of 0.6 cm that
is suggested by NCRP Report 49 was the most frequently
used HVL value for Iridium-192 (47.3%).3) Thirteen
radiation safety reports (34.2%) either did not use lead for
facility shielding or did not include HVL for shielding
calculations.
TVL mentioned here are first tenth-value layers (TVL1)
and equilibrium tenth-value layers (TVLe) have not been
assessed since most radiation safety reports did not consider
the spectral changes of radiation emitted from Ir-192 sources.
4. DISCUSSION
This study evaluated the quality of radiation safety
reports of the current brachytherapy units in Korea, which
were installed between 1985 and 2010. The majority of the
brachytherapy units in the radiation oncology departments
in Korea were supplied by Nucletron (63,2%), followed by
Varian (13.2%) and MDS Nordion (10.5%). All 38 radiation
oncology departments treated their patients with the HDR
brachytherapy technique. However, four departments had
brachytherapy units that could treat patients with both LDR
and HDR techniques via interchangeable sources. 
National as well as international guidelines stipulate
that radiation safety reports should contain the personal
information of the drafter. A significant number of the
reports (47.4%) included this information. Moreover, 28.9%
of the reports were completed by radiation oncology
department-affiliated people while 18.4% were completed
by outsourcing companies; the remaining reports did not
provide drafter information.
Factors used for shielding calculations, namely exposure
rate constant and HVL value, showed acceptable variation.
The exposure rate constant values for Iridium-192 sources
used in workload calculation varied acceptably between
0.469 and 0.592 R·m2/Ci·hr. The HVLs of concrete, steel
and lead for the Iridium-192 sources that were used for
shielding calculation did not vary significantly.
However, the treatment time per week, which was
used to calculate workload, varied widely (ranging from
12 to 2,400 min/week). The treatment time approximation
that was most frequently employed (28.9% of all reports
used this) was 40 hr/week, which is a typical treatment
time for linear accelerators. Due to the limitations of this
study, the estimated treatment time used for calculating
workload could not be compared to the actual treatment
time. Therefore, we cannot conclude whether treatment
times of 12 or 2400 min/week were actually used in the
clinic, or whether these estimations are incorrect. However
given the average treatment time estimations that were
suggested by Glasgow and Dillman (120 min/week) and
NCRP Report 151 (402 min/week), a treatment time of
2,400 min/week seems likely to be an overstatement 4, 7).
The evaluated TVLs are first tenth-value layers (TVL1)
and equilibrium tenth-value layers (TVLe) have not been
assessed since most radiation safety reports did not consider
the spectral changes of Ir-192 sources possibly due to the
low energy of radiation emitted. 
The installation of brachytherapy units has been
decreasing since 2001. Nevertheless, it is still necessary
to ensure appropriate and safe radiation facility shielding.
Moreover, it can be expected that older brachytherapy
machines will eventually have to be replaced with new
units. It should also be remembered that given the current
preference for brachytherapy treatment with HDR tech-
niques, even minor mistakes could result in significant
consequences. While such accidents are believed to be
generally under-reported, ICRP Publication 97 states that
over 500 HDR events have been recorded.8) One of the
most severe incidents involved a patient receiving interstitial
HDR treatment for anorectal cancer. An error occurred
while the source was being inserted in the catheter and it
went unnoticed that the source was left in the body. The
patient died five days later as a result of this grave error.8)
One potential problem is that with the introduction of
outsourcing agencies, more centers are relying on these
agencies for completing radiation safety reports. While these
agencies are well-trained and possess expert knowledge
in the completion of radiation safety reports, they are not
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Fig. 6. Histogram of the Half-value-layer of Concrete for
Iridium-192 Sources that were used.
(3)
(4)
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aware of the actual clinical environment and the status of
technical advancements in the radiation oncology field.
Although, the development of brachytherapy technique is
not as rapid as that of EBRT it cannot be ensured that the
possible changes have been reflected accurately in the
radiation safety reports. Moreover, persons completing
radiation safety reports who are affiliated with the institu-
tions may not possess expert knowledge in radiation pro-
tection and shielding, since they are mainly medical physi-
cists and not radiation safety officers. Thus, more practical
guidelines should be in place for drafters to reference from,
when completing the radiation safety reports. The results of
the present study may aid the development of such guide-
lines for completing radiation safety reports for brachyther-
apy equipment in radiation oncology departments in Korea. 
5. CONCLUSION
The present study revealed that although the majority
of radiation oncology institutions showed good agreement
in terms of completing radiation safety reports, a few of the
reports varied in estimations of the treatment time, which
in turn led to variations in the estimations of workload.
The need to ensure safety when operating brachytherapy
equipment, the fact that new brachytherapy units are likely
to be installed in the future, and the fact that outsourcing
agencies are increasingly being used to complete radiation
safety reports means that standard guidelines that more
realistically reflect the current clinical situation of radiation
oncology departments in Korea are needed. 
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